SIGLEC5
Sialic acid-binding Ig-like lectin 5
Also known as: CD170, CD33L2, OB-BP2, SIGL5_HUMAN, SIGLEC-5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15389
- Gene
- SIGLEC5
- Ensembl
- ENSG00000268500
- Chromosome
- 19
- Canonical length
- 551 aa
- Protein class
- CD markers, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. These cell surface lectins are characterized by structural motifs in the immunoglobulin (Ig)-like domains and sialic acid recognition sites in the first Ig V set domain. The encoded protein is a member of the CD33-related subset of Siglecs and inhibits the activation of several cell types including monocytes, macrophages and neutrophils. Binding of group B Streptococcus (GBS) to the encoded protein plays a role in GBS immune evasion. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
551 residues, UniProt reviewed canonical sequence.
>O15389|SIGLEC5
1 MLPLLLLPLL WGGSLQEKPV YELQVQKSVT VQEGLCVLVP CSFSYPWRSW YSSPPLYVYW
61 FRDGEIPYYA EVVATNNPDR RVKPETQGRF RLLGDVQKKN CSLSIGDARM EDTGSYFFRV
121 ERGRDVKYSY QQNKLNLEVT ALIEKPDIHF LEPLESGRPT RLSCSLPGSC EAGPPLTFSW
181 TGNALSPLDP ETTRSSELTL TPRPEDHGTN LTCQMKRQGA QVTTERTVQL NVSYAPQTIT
241 IFRNGIALEI LQNTSYLPVL EGQALRLLCD APSNPPAHLS WFQGSPALNA TPISNTGILE
301 LRRVRSAEEG GFTCRAQHPL GFLQIFLNLS VYSLPQLLGP SCSWEAEGLH CRCSFRARPA
361 PSLCWRLEEK PLEGNSSQGS FKVNSSSAGP WANSSLILHG GLSSDLKVSC KAWNIYGSQS
421 GSVLLLQGRS NLGTGVVPAA LGGAGVMALL CICLCLIFFL IVKARRKQAA GRPEKMDDED
481 PIMGTITSGS RKKPWPDSPG DQASPPGDAP PLEEQKELHY ASLSFSEMKS REPKDQEAPS
541 TTEYSEIKTS KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIGLEC5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 28 nTPM
- appendix: 12 nTPM
- spleen: 9.6 nTPM
- lymph node: 4.6 nTPM
- lung: 2.7 nTPM
- tonsil: 2.6 nTPM
Single-cell type
- neutrophils: 424 nCPM
- neutrophil progenitors: 133 nCPM
- monocytes: 28 nCPM
- kupffer cells: 26 nCPM
- hofbauer cells: 22 nCPM
- monocyte progenitors: 16 nCPM
Immune cell
- neutrophil: 285 nTPM
- non-classical monocyte: 96 nTPM
- intermediate monocyte: 46 nTPM
- classical monocyte: 45 nTPM
- myeloid DC: 31 nTPM
- basophil: 26 nTPM
Brain region
- cerebral cortex: 9.5 nTPM
- pons: 3.5 nTPM
- white matter: 2.6 nTPM
- thalamus: 1.9 nTPM
- medulla oblongata: 1.8 nTPM
- spinal cord: 1.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIGLEC5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIGLEC5 as an antibody target. Whether an autoantibody or antibody against SIGLEC5 could matter depends on whether native SIGLEC5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIGLEC5 is annotated at the cell surface, where native SIGLEC5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIGLEC5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...